(Q54729569)

3 June 2018

title

Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy. (English)

1 reference

3 June 2018

main subject

venous thromboembolism

1 reference

0 references

Jeffrey K Wang

1

1 reference

3 June 2018

Stephen A Boorjian

2

1 reference

3 June 2018

Igor Frank

3

1 reference

3 June 2018

Robert F Tarrell

4

1 reference

3 June 2018

Prabin Thapa

5

1 reference

3 June 2018

Eapen K Jacob

6

1 reference

3 June 2018

Craig D Tauscher

7

1 reference

3 June 2018

Matthew K Tollefson

8

1 reference

3 June 2018

language of work or name

English

0 references

publication date

16 October 2013

1 reference

3 June 2018

published in

Urology

1 reference

3 June 2018

volume

83

1 reference

3 June 2018

issue

1

1 reference

3 June 2018

page(s)

140-145

1 reference

3 June 2018

The changing pattern of mortality and morbidity from radical cystectomy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

Low molecular weight heparin and radical prostatectomy: a prospective analysis of safety and side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

Venous thromboembolism: disease burden, outcomes and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

Influence of ABO blood groups on primary hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

How important are ABO-related variations in coagulation factor levels?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

ABO(H) blood groups and vascular disease: a systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

Interaction between blood type, smoking and factor V Leiden mutation and risk of venous thromboembolism: a Danish case-cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.08.046

10.1016/J.UROLOGY.2013.08.046

7 January 2021

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018